相似文献
1
Novel assessment of epigenetic imprinting biomarkers for the diagnosis of thyroid nodules.
Nat Rev Clin Oncol. 2023 Mar;20(3):139-140. doi: 10.1038/s41571-022-00720-3.
2
High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules.
J Clin Oncol. 2023 Feb 20;41(6):1296-1306. doi: 10.1200/JCO.22.00232. Epub 2022 Nov 15.
3
Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics.
Clin Cancer Res. 2019 Jan 15;25(2):544-551. doi: 10.1158/1078-0432.CCR-18-0841. Epub 2018 Aug 9.
4
Search for genetic mutations in cytological samples from thyroid nodules as a diagnostic tool: reality, hope or myth?
J Endocrinol Invest. 2010 Sep;33(8):576-8. doi: 10.1007/BF03346651.
5
Getting more out of molecular testing for indeterminate thyroid nodules.
Cancer Cytopathol. 2019 Sep;127(9):555-556. doi: 10.1002/cncy.22129. Epub 2019 Jun 25.
6
The utility of molecular markers in pre-operative assessment of thyroid nodules.
Future Oncol. 2015;11(16):2343-50. doi: 10.2217/fon.15.135.
7
Thyroid Nodule Molecular Testing: Is It Ready for Prime Time?
Front Endocrinol (Lausanne). 2020 Oct 9;11:590128. doi: 10.3389/fendo.2020.590128. eCollection 2020.
8
Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers.
Eur J Endocrinol. 2022 Jul 19;187(3):335-347. doi: 10.1530/EJE-22-0012. Print 2022 Sep 1.
9
Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
BMC Cancer. 2020 Mar 12;20(1):199. doi: 10.1186/s12885-020-6676-z.
10
The role of genetic markers in the evaluation and management of thyroid nodules.
Surg Clin North Am. 2014 Jun;94(3):515-28. doi: 10.1016/j.suc.2014.03.001. Epub 2014 Apr 24.
引用本文的文献
1
Coagulation and thyroiditis are factors associated with adverse pathological features in differentiated thyroid cancer: a retrospective cohort study.
BMC Surg. 2025 Apr 11;25(1):150. doi: 10.1186/s12893-025-02898-6.
本文引用的文献
1
High Diagnostic Accuracy of Epigenetic Imprinting Biomarkers in Thyroid Nodules.
J Clin Oncol. 2023 Feb 20;41(6):1296-1306. doi: 10.1200/JCO.22.00232. Epub 2022 Nov 15.
2
Diagnostic Accuracy of Fine-Needle Biopsy in the Detection of Thyroid Malignancy: A Systematic Review and Meta-analysis.
JAMA Surg. 2022 Dec 1;157(12):1105-1113. doi: 10.1001/jamasurg.2022.4989.
3
Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
Thyroid. 2022 Oct;32(10):1144-1157. doi: 10.1089/thy.2022.0269. Epub 2022 Sep 26.
4
The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
Thyroid. 2022 Aug;32(8):905-916. doi: 10.1089/thy.2021.0659. Epub 2022 Jun 23.
5
Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment.
BMJ. 2020 Jan 7;368:l6670. doi: 10.1136/bmj.l6670.
6
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
7
Physical exam in asymptomatic people drivers the detection of thyroid nodules undergoing ultrasound guided fine needle aspiration biopsy.
Endocrine. 2016 Nov;54(2):433-439. doi: 10.1007/s12020-016-1054-y. Epub 2016 Aug 10.
8
9
The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.
Acta Cytol. 2012;56(4):333-9. doi: 10.1159/000339959. Epub 2012 Jul 25.
10
Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination.
Eur J Clin Invest. 2009 Aug;39(8):699-706. doi: 10.1111/j.1365-2362.2009.02162.x.
Zotero 插件